{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:47:00Z","timestamp":1792669620690,"version":"4.5.0"},"reference-count":92,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/wno.0b013e318238937f","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T19:23:44Z","timestamp":1321471424000},"page":"362-373","source":"Crossref","is-referenced-by-count":113,"title":["Vision in Multiple Sclerosis"],"prefix":"10.1097","volume":"31","author":[{"given":"Reiko E.","family":"Sakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Feller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven L.","family":"Galetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Balcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-15-20210126","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-2456(93)90015-6","article-title":"Design, methods, and conduct of the Optic Neuritis Treatment Trial.","volume":"14","author":"Cleary","year":"1993","journal-title":"Control Clin Trials"},{"key":"R4-15-20210126","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9394(14)75429-7","article-title":"Contrast sensitivity and other vision tests in the optic neuritis treatment trial.","volume":"121","author":"Trobe","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R5-15-20210126","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archopht.126.7.996","article-title":"The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results.","volume":"126","author":"Volpe","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R7-15-20210126","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1212\/01.WNL.0000094315.19931.90","article-title":"Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite.","volume":"61","author":"Balcer","year":"2003","journal-title":"Neurology"},{"key":"R8-15-20210126","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis.","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"R9-15-20210126","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1212\/01.wnl.0000259521.14704.a8","article-title":"Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.","volume":"68","author":"Balcer","year":"2007","journal-title":"Neurology"},{"key":"R10-15-20210126","first-page":"S183","article-title":"Low-contrast acuity measures visual improvement in a phase 3 trial of natalizumab in relapsing MS.","volume":"16","author":"Balcer","year":"2010","journal-title":"Mult Scler"},{"key":"R11-15-20210126","first-page":"1409","article-title":"Eye disorders in patients with multiple sclerosis: natural history and management.","volume":"4","author":"Graves","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"R12-15-20210126","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis.","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"R13-15-20210126","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/brain\/124.9.1813","article-title":"Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis.","volume":"124","author":"Evangelou","year":"2001","journal-title":"Brain"},{"key":"R14-15-20210126","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awl074","article-title":"The contribution of demyelination to axonal loss in multiple sclerosis.","volume":"129","author":"DeLuca","year":"2006","journal-title":"Brain"},{"key":"R15-15-20210126","first-page":"2520","article-title":"Correlation between morphological and functional retinal impairment in multiple sclerosis patients.","volume":"40","author":"Parisi","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-15-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ana.21436","article-title":"Gray matter atrophy in multiple sclerosis: a longitudinal study.","volume":"64","author":"Fisher","year":"2008","journal-title":"Ann Neurol"},{"key":"R17-15-20210126","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1212\/01.wnl.0000250267.85698.7a","article-title":"Gray matter involvement in multiple sclerosis.","volume":"68","author":"Pirko","year":"2007","journal-title":"Neurology"},{"key":"R18-15-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.21423","article-title":"Gray matter atrophy is related to long-term disability in multiple sclerosis.","volume":"64","author":"Fisniku","year":"2008","journal-title":"Ann Neurol"},{"key":"R19-15-20210126","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2009.01.012","article-title":"Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging.","volume":"282","author":"Chard","year":"2009","journal-title":"J Neurol Sci"},{"key":"R20-15-20210126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","article-title":"Quantifying axonal loss after optic neuritis with optical coherence tomography.","volume":"59","author":"Costello","year":"2006","journal-title":"Ann Neurol"},{"key":"R21-15-20210126","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ana.20575","article-title":"Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis.","volume":"58","author":"Trip","year":"2005","journal-title":"Ann Neurol"},{"key":"R22-15-20210126","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis.","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"R23-15-20210126","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1474-4422(06)70573-7","article-title":"Optical coherence tomography in multiple sclerosis.","volume":"5","author":"Frohman","year":"2006","journal-title":"Lancet Neurol"},{"key":"R24-15-20210126","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0950","article-title":"Optical coherence tomography: a window into the mechanisms of multiple sclerosis.","volume":"4","author":"Frohman","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"R25-15-20210126","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13311-010-0005-1","article-title":"Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration.","volume":"8","author":"Galetta","year":"2011","journal-title":"Neurotherapeutics"},{"key":"R26-15-20210126","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","article-title":"Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.","volume":"9","author":"Petzold","year":"2010","journal-title":"Lancet Neurol"},{"key":"R27-15-20210126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrneurol.2009.41","article-title":"Imaging outcomes for neuroprotection and repair in multiple sclerosis trials.","volume":"5","author":"Barkhof","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"R28-15-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/WCO.0b013e328334e99b","article-title":"Optical coherence tomography of the retina: applications in neurology.","volume":"23","author":"Jindahra","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"R29-15-20210126","first-page":"E105","article-title":"The use of optical coherence tomography in neurology.","volume":"6","author":"Lameril","year":"2009","journal-title":"Rev Neurol Dis"},{"key":"R30-15-20210126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1442-9071.2009.02015.x","article-title":"Optical coherence tomography of the retina and optic nervea review.","volume":"37","author":"Sakata","year":"2009","journal-title":"Clin Exp Ophthalmol"},{"key":"R31-15-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.nic.2008.09.003","article-title":"Nonconventional optic nerve imaging in multiple sclerosis.","volume":"19","author":"Glisson","year":"2009","journal-title":"Neuroimag Clin N Am"},{"key":"R32-15-20210126","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1468-1331.2007.01736.x","article-title":"Optical coherence tomography in optic neuritis and multiple sclerosis: a review.","volume":"14","author":"Kallenbach","year":"2007","journal-title":"Eur J Neurol"},{"key":"R33-15-20210126","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.410420318","article-title":"Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force.","volume":"42","author":"Rudick","year":"1997","journal-title":"Ann Neurol"},{"key":"R34-15-20210126","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.410400321","article-title":"Clinical outcomes assessment in multiple sclerosis.","volume":"40","author":"Rudick","year":"1996","journal-title":"Ann Neurol"},{"key":"R35-15-20210126","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archneur.57.9.1319","article-title":"Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.","volume":"57","author":"Miller","year":"2000","journal-title":"Arch Neurol"},{"key":"R36-15-20210126","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1191\/1352458502ms845oa","article-title":"The multiple sclerosis functional composite: a new clinical outcome measure for multiple sclerosis trials.","volume":"8","author":"Rudick","year":"2002","journal-title":"Mult Scler"},{"key":"R37-15-20210126","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1191\/1352458504ms1111oa","article-title":"Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test.","volume":"10","author":"Ozakbas","year":"2004","journal-title":"Mult Scler"},{"key":"R38-15-20210126","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1177\/1352458509106212","article-title":"Assessing disability progression with the Multiple Sclerosis Functional Composite.","volume":"15","author":"Rudick","year":"2009","journal-title":"Mult Scler"},{"key":"R39-15-20210126","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00155090","article-title":"Visual function in multiple sclerosis.","volume":"73","author":"Ashworth","year":"1989","journal-title":"Doc Ophthalmol"},{"key":"R40-15-20210126","first-page":"284","article-title":"Hidden visual loss in optic neuropathy is revealed using Gabor patch contrast perimetry.","volume":"4","author":"Bodis-Wollner","year":"1997","journal-title":"Clin Neurosci"},{"key":"R41-15-20210126","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/104.2.333","article-title":"Contrast sensitivity, visual acuity and the discrimination of Snellen letters in multiple sclerosis.","volume":"104","author":"Regan","year":"1981","journal-title":"Brain"},{"key":"R42-15-20210126","first-page":"141","article-title":"Value of Pelli-Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients.","volume":"41","author":"Wender","year":"2007","journal-title":"Neurol Neurochir Pol"},{"key":"R43-15-20210126","first-page":"632","article-title":"Contrast sensitivity loss in multiple sclerosis. Selectivity by eye, orientation, and spatial frequency measured with the evoked potential.","volume":"25","author":"Kupersmith","year":"1984","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R44-15-20210126","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00006324-199904000-00023","article-title":"What is low vision A re-evaluation of definitions.","volume":"76","author":"Leat","year":"1999","journal-title":"Optom Vis Sci"},{"key":"R45-15-20210126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/135245850000600305","article-title":"New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis.","volume":"6","author":"Balcer","year":"2000","journal-title":"Mult Scler"},{"issue":"suppl 3","key":"R46-15-20210126","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.0b013e3181dbb664","article-title":"Evaluating loss of visual function in multiple sclerosis as measured by low-contrast letter acuity.","volume":"74","author":"Balcer","year":"2010","journal-title":"Neurology"},{"key":"R47-15-20210126","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis.","volume":"67","author":"Talman","year":"2010","journal-title":"Ann Neurol"},{"key":"R49-15-20210126","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0002-9394(02)01337-5","article-title":"Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire.","volume":"133","author":"Ma","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"R50-15-20210126","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ajo.2006.06.060","article-title":"Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25.","volume":"142","author":"Raphael","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R51-15-20210126","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.2008.165449","article-title":"Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity.","volume":"80","author":"Mowry","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R56-15-20210126","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajo.2011.01.023","article-title":"One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis.","volume":"152","author":"Pineles","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"R57-15-20210126","first-page":"95","article-title":"Binocular visual function in patients with a history of monocular optic neuritis.","volume":"6","author":"Newman","year":"1991","journal-title":"Clin Vis Sci"},{"key":"R58-15-20210126","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1212\/01.wnl.0000278387.15090.5a","article-title":"Relation of vision to global and regional brain MRI in multiple sclerosis.","volume":"69","author":"Wu","year":"2007","journal-title":"Neurology"},{"key":"R59-15-20210126","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00415-009-0123-z","article-title":"Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.","volume":"256","author":"Kolappan","year":"2009","journal-title":"J Neurol"},{"key":"R60-15-20210126","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/bmj.4.5893.661","article-title":"Visual evoked response in diagnosis of multiple sclerosis.","volume":"4","author":"Halliday","year":"1973","journal-title":"BMJ"},{"key":"R61-15-20210126","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1212\/WNL.0b013e3181c3fd43","article-title":"Evaluation of optic neuropathy in multiple sclerosis using low-contrast visual evoked potentials.","volume":"73","author":"Thurtell","year":"2009","journal-title":"Neurology"},{"key":"R62-15-20210126","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1177\/1352458509350470","article-title":"Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.","volume":"15","author":"Laron","year":"2009","journal-title":"Mult Scler"},{"key":"R63-15-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","article-title":"Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.","volume":"73","author":"Naismith","year":"2009","journal-title":"Neurology"},{"key":"R64-15-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archneurol.2008.562","article-title":"Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.","volume":"66","author":"Sepulcre","year":"2009","journal-title":"Arch Neurol"},{"key":"R65-15-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1212\/WNL.26.6_Part_2.26","article-title":"Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States.","volume":"26","author":"Ikuta","year":"1976","journal-title":"Neurology"},{"key":"R66-15-20210126","first-page":"211","article-title":"Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis.","volume":"3","author":"Toussaint","year":"1983","journal-title":"J Clin Neuro-Ophthalmol"},{"key":"R67-15-20210126","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1167\/iovs.03-1213","article-title":"Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.","volume":"46","author":"Sisto","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R68-15-20210126","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s004150170029","article-title":"Asymptomatic visual loss in multiple sclerosis.","volume":"248","author":"Lycke","year":"2001","journal-title":"J Neurol"},{"key":"R69-15-20210126","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1755-3768.1987.tb07073.x","article-title":"Subclinical optic neuropathy in multiple sclerosis. A neuro-ophthalmological investigation by means of visually evoked response, Farnworth-Munsell 100 Hue test and Ishihara test and their diagnostic value.","volume":"65","author":"Engell","year":"1987","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R70-15-20210126","doi-asserted-by":"crossref","first-page":"5798","DOI":"10.1167\/iovs.07-0738","article-title":"The relationship between visual field and retinal nerve fiber layer measurements in patients with multiple sclerosis.","volume":"48","author":"Cheng","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R71-15-20210126","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/01.wnl.0000294876.49861.dc","article-title":"Optical coherence tomography and disease subtype in multiple sclerosis.","volume":"69","author":"Pulicken","year":"2007","journal-title":"Neurology"},{"key":"R72-15-20210126","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2009.02.354","article-title":"Differences in retinal nerve fiber layer atrophy between multiple sclerosis subtypes.","volume":"281","author":"Costello","year":"2009","journal-title":"J Neurol Sci"},{"key":"R73-15-20210126","first-page":"277","article-title":"An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography.","volume":"131","author":"Henderson","year":"2008","journal-title":"Brain"},{"key":"R74-15-20210126","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis.","volume":"69","author":"Gordon-Lipkin","year":"2007","journal-title":"Neurology"},{"key":"R75-15-20210126","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1212\/01.wnl.0000260612.51849.ed","article-title":"Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.","volume":"68","author":"Sepulcre","year":"2007","journal-title":"Neurology"},{"key":"R76-15-20210126","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archneur.65.9.1218","article-title":"Reproducibility of optical coherence tomography in multiple sclerosis.","volume":"65","author":"Cettomai","year":"2008","journal-title":"Arch Neurol"},{"key":"R77-15-20210126","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archneur.65.7.924","article-title":"Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.","volume":"65","author":"Zaveri","year":"2008","journal-title":"Arch Neurol"},{"key":"R78-15-20210126","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/1352458508100503","article-title":"Retinal architecture predicts pupillary reflex metrics in MS.","volume":"15","author":"Salter","year":"2008","journal-title":"Mult Scler"},{"key":"R79-15-20210126","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1755-3768.2009.01527.x","article-title":"Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis.","volume":"88","author":"Pueyo","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R80-15-20210126","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1017\/S031716710000915X","article-title":"Retinal nerve fiber layer and future risk of multiple sclerosis.","volume":"35","author":"Costello","year":"2008","journal-title":"Can J Neurol Sci"},{"key":"R81-15-20210126","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/archneurol.2009.230","article-title":"Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis.","volume":"66","author":"Burkholder","year":"2009","journal-title":"Arch Neurol"},{"key":"R82-15-20210126","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/1352458510371640","article-title":"Reproducibility of high-resolution optical coherence tomography in multiple sclerosis.","volume":"16","author":"Syc","year":"2010","journal-title":"Mult Scler"},{"key":"R83-15-20210126","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000070634","article-title":"Evaluation of the effect of aging on retinal nerve fiber layer thickness measured by optical coherence tomography.","volume":"217","author":"Kanamori","year":"2003","journal-title":"Ophthalmologica"},{"key":"R84-15-20210126","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1093\/brain\/awq146","article-title":"A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials.","volume":"133","author":"Henderson","year":"2010","journal-title":"Brain"},{"key":"R85-15-20210126","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3129\/i10-063","article-title":"Using retinal architecture to help characterize multiple sclerosis patients.","volume":"45","author":"Costello","year":"2010","journal-title":"Can J Ophthalmol"},{"key":"R87-15-20210126","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/112067211002000122","article-title":"Retinal nerve fiber layer thickness and spatial and temporal contrast sensitivity in multiple sclerosis.","volume":"20","author":"Merle","year":"2010","journal-title":"Eur J Ophthalmol"},{"key":"R89-15-20210126","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.neuroimage.2009.09.005","article-title":"A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions.","volume":"49","author":"Shiee","year":"2010","journal-title":"NeuroImage"},{"key":"R90-15-20210126","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1212\/WNL.0b013e3181ff96f6","article-title":"Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.","volume":"75","author":"Filippi","year":"2010","journal-title":"Neurology"},{"key":"R91-15-20210126","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/archneurol.2010.148","article-title":"Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging.","volume":"67","author":"Pitt","year":"2010","journal-title":"Arch Neurol"},{"key":"R92-15-20210126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/WNO.0b013e3181facbbd","article-title":"Comparison of retinal nerve fiber layer and central macular thickness measurements among five different optical coherence tomography instruments in patients with multiple sclerosis and optic neuritis.","volume":"31","author":"Watson","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R93-15-20210126","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/j.1755-3768.2010.02045.x","article-title":"Intra and inter-operator reproducibility of retinal nerve fiber and macular thickness measurements using Cirrus Fourier-domain OCT.","volume":"89","author":"Garcia-Martin","year":"2011","journal-title":"Acta Ophthalmol"},{"key":"R94-15-20210126","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/IAE.0b013e3181bd2c3b","article-title":"Comparison of spectral domain optical coherence tomography instruments for assessment of normal macular thickness.","volume":"30","author":"Sull","year":"2010","journal-title":"Retina"},{"key":"R96-15-20210126","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1093\/brain\/awq346","article-title":"Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography.","volume":"134","author":"Saidha","year":"2011","journal-title":"Brain"},{"key":"R97-15-20210126","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/WNO.0b013e318221b434","article-title":"Retinal ganglion cell layer volumetric assessment by spectral-domain optical coherence tomography in multiple sclerosis: application of a high-precision manual estimation technique.","volume":"31","author":"Davies","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R99-15-20210126","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ophtha.2009.05.025","article-title":"Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography.","volume":"116","author":"Tan","year":"2009","journal-title":"Ophthalmology"},{"key":"R100-15-20210126","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1167\/iovs.04-0335","article-title":"Macular segmentation with optical coherence tomography.","volume":"46","author":"Ishikawa","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R101-15-20210126","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/brain\/awq080","article-title":"Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.","volume":"133","author":"Green","year":"2010","journal-title":"Brain"},{"key":"R102-15-20210126","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/WNO.0b013e3181f7f833","article-title":"Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.","volume":"30","author":"Shindler","year":"2010","journal-title":"J Neuroophthalmol"},{"key":"R104-15-20210126","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/01658107.2011.557760","article-title":"Stratus OCT quality control in two multi-centre multiple sclerosis clinical trials.","volume":"35","author":"Keltner","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"R105-15-20210126","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/eye.2010.218","article-title":"Outer retinal abnormalities associated with inner retinal pathology in nonglaucomatous and glaucomatous optic neuropathies.","volume":"25","author":"Werner","year":"2011","journal-title":"Eye"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e318238937f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T19:46:20Z","timestamp":1713123980000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201112000-00015"}},"subtitle":["The Story, Structure-Function Correlations, and Models for Neuroprotection"],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":92,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e318238937f","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}